American Association for Cancer Research
15357163mct090508-sup-stab_2.xls (25 kB)

Supplementary Table 2 from Molecular Evolutionary Analysis of Cancer Cell Lines

Download (25 kB)
posted on 2023-03-31, 23:21 authored by Yan Zhang, Michael J. Italia, Kurt R. Auger, Wendy S. Halsey, Stephanie F. Van Horn, Ganesh M. Sathe, Michal Magid-Slav, James R. Brown, Joanna D. Holbrook
Supplementary Table 2 from Molecular Evolutionary Analysis of Cancer Cell Lines



With genome-wide cancer studies producing large DNA sequence data sets, novel computational approaches toward better understanding the role of mutations in tumor survival and proliferation are greatly needed. Tumors are widely viewed to be influenced by Darwinian processes, yet molecular evolutionary analysis, invaluable in other DNA sequence studies, has seen little application in cancer biology. Here, we describe the phylogenetic analysis of 353 cancer cell lines based on multiple sequence alignments of 3,252 nucleotides and 1,170 amino acids built from the concatenation of variant codons and residues across 494 and 523 genes, respectively. Reconstructed phylogenetic trees cluster cell lines by shared DNA variant patterns rather than cancer tissue type, suggesting that tumors originating from diverse histologies have similar oncogenic pathways. A well-supported clade of 91 cancer cell lines representing multiple tumor types also had significantly different gene expression profiles from the remaining cell lines according to statistical analyses of mRNA microarray data. This suggests that phylogenetic clustering of tumor cell lines based on DNA variants might reflect functional similarities in cellular pathways. Positive selection analysis revealed specific DNA variants that might be potential driver mutations. Our study shows the potential role of molecular evolutionary analyses in tumor classification and the development of novel anticancer strategies. Mol Cancer Ther; 9(2); 279–91